FirmaIQ
Org.nr 923 831 762 AS · OSLO · 72.100 Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk Ullernchausséen 64, 0379 OSLO Latest filing: Årsregnskap 2025 · approved 18.05.2026 · journal 2026 559231 Analysis generated: 24 Aug 2026 · Auto-onboard

ADJUTEC PHARMA AS

ADJUTEC PHARMA AS · 7 published annual accounts (2019–2025). Latest year revenue 0 NOK, net result -1.1m NOK, equity 47.2m NOK, cash 16.3m NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R2019–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Simple version

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About —

Operating income / revenue in 2025.

Did they make money?
-1.1m

Net result for 2025.

What’s left in the company
Equity 47.2m

Book equity at year-end.

Cash
16.3m

Bank deposits and cash (when disclosed).

At a glance · 2025

Key figures

Revenue / sales
—
NOK · [R2025]
Net result
-1 122 056
NOK · [R2025]
Equity
47 221 405
NOK · [R2025]
Cash
16 294 500
NOK · [R2025]
Total assets
66 373 991
NOK · [R2025]
Paid-in equity
80 746 259
NOK · [R2025]

Trends

7-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.